TREATMENT OF DRUG-INDUCED PARKINSONISM: A COMPARISON BETWEEN UK-738, ORPHENADRINE, AND A PLACEBO IN A DOUBLE BLIND STUDY.
D003006:Clopenthixol; D004311:Double-Blind Method; D004358:Drug Therapy; D005116:Extrapyramidal Tracts; D006220:Haloperidol; D006801:Humans; D009966:Orphenadrine; D010276:Parasympatholytics; D020734:Parkinsonian Disorders; D010546:Perphenazine; D010919:Placebos; D014149:Tranquilizing Agents
D010276:Parasympatholytics; D010919:Placebos; D014149:Tranquilizing Agents; D003006:Clopenthixol; D009966:Orphenadrine; D010546:Perphenazine; D006220:Haloperidol
CLOPENTHIXOL; DRUG THERAPY; EXTRAPYRAMIDAL TRACTS; HALOPERIDOL; ORPHENADRINE; PARASYMPATHOLYTICS; PARKINSONISM; PERPHENAZINE; PLACEBOS; TRANQUILIZING AGENTS